Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023
07 Agosto 2023 - 9:00AM
Business Wire
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic
DNA using its silicon platform, today announced that Patrick Finn,
Ph.D., president and COO of Twist Bioscience, will participate in
the Innovation Across Drug Discovery, Molecule Synthesis, &
Precision Medicine panel at the UBS MedTech, Tools and Genomics
Summit 2023 on Tuesday, August 15 at 2:00 p.m. Pacific Time.
The panel will be webcast live and can be accessed by visiting
the “Investor Calendar” page of the investor relations section of
the company's website here. A replay of the presentation will be
archived for a period of 30 days following the conclusion of the
live events.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by “writing” DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research.
Follow us on Twitter | Facebook | LinkedIn | YouTube
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230807075304/en/
For Twist Bioscience: Angela Bitting SVP, Corporate
Affairs 925-202-6211 abitting@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Twist Bioscience (NASDAQ:TWST)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024